The BioNTech SE ADR BNTX rose 4.79% to $118.47 Tuesday, on what proved to be an all-around great trading session for the ...

BioNTech has been boosted a wave of enthusiasm over another company’s cancer drug, which has turned the biopharma industry ...

In a report released today, Terence Flynn from Morgan Stanley maintained a Hold rating on BioNTech SE (BNTX – Research Report), with a ...

BioNTech SE Sponsored ADR (BNTX) shares soared 5.8% in the last trading session to close at $105. The move was backed by solid volume with far more shares changing hands than in a normal session. This ...

BioNTech (BNTX) stock traded higher on Tuesday after Jefferies upgraded the COVID-19 vaccine maker to Buy, citing the ...

Take a look at the current price of BioNTech stock and decide how much money you can afford to invest. Calculate how many shares you can purchase with your investment funds using the current ...

Jefferies analyst Akash Tewari upgraded BioNTech SE (BNTX – Research Report) to a Buy today and set a price target of $150.00. The ...

BioNTech's shares have experienced a remarkable upswing, with the stock price soaring to $130.90 on NASDAQ, marking a 6.0% increase in the latest session. This surge represents a significant recovery ...

On Friday, Jefferies, a financial services company, increased its price target on shares of BioNTech (NASDAQ:BNTX), listed on NASDAQ:BNTX, to $96 from the previous $90 while maintaining a Hold rating ...

The BioNTech SE ADR BNTX inched 0.69% higher to $113.05 Monday, on what proved to be an all-around positive trading session ...

empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements. For BioNTech, the consensus EPS estimate for the quarter has been ...